Moreover, we used standard SPR and reversible multimers technology to assess TCR-pHLA structural affinities (31, 78), however, it would also be interesting to see how other binding parameters, including 2D affinity (79, 80) and catch-bond formation (81), would categorize those vaccine- versus tumor-derived CD8 T cells. Here, CD8A is linked to neoplasm.